Every time there is a new regulation requested by the government, or generated by the industry needs, our scientific and technical contributions not only help us to remain updated but also aware of the philosophy underlying new regulations. Dr Emmanuelle Voisin, CEO, VCLS spoke on the trends in regulation and how India fits into her plans to build an affordable innovative chain, from discovery to market.
Emmanuelle Voisin
Building an affordable innovative drug development chain
2009 – Express India